TY - CHAP A1 - Thomas J. FitzGerald A2 - Maryann Bishop-Jodoin A3 - Fran Laurie A4 - Richard Hanusik A5 - Matthew Iandoli A6 - Kathryn Karolczuk A7 - Sandra Kessel A8 - Fred Prior A9 - Joel Saltz A10 - Ashish Sharma A11 - Michael Knopp A12 - Mark Rosen A13 - Ying Xiao A14 - David Followill A15 - Jeff Michalski A16 - Ameer Elaimy A17 - James Shen A18 - Peter Lee A19 - Maria Giulia Cicchetti A20 - Janaki Moni ED1 - Sivapatham Sundaresan ED2 - Yeun-Hwa Gu Y1 - 2021-02-03 PY - 2021 T1 - Acquisition and Management of Data for Translational Science in Oncology N2 - Translational research in oncology benefits from an abundance of knowledge resulting from genome-scale studies concerning the molecular pathways involved in tumorigenesis. Translational oncology represents a bridge between basic research and clinical practice in cancer medicine. The vast majority of cancer cases are due to environmental risk factors. Many of these environmental factors are controllable lifestyle choices. Experimental cancer treatments are studied in clinical trials to compare the proposed treatment to the best existing treatment through translational research. The key features of the book include: 1) New screening for the development of radioprotectors: radioprotection and anti-cancer effect of β-Glucan (Enterococcus faecalis) 2) Translational perspective on hepatocellular carcinoma 3) Brachytherapy for endometrial cancer 4) Discovery of small molecule inhibitors for histone methyltransferases in cancer BT - Translational Research in Cancer SP - Ch. 11 UR - https://doi.org/10.5772/intechopen.89700 DO - 10.5772/intechopen.89700 SN - 978-1-83880-535-7 PB - IntechOpen CY - Rijeka Y2 - 2021-09-23 ER -